Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)
  7. News

ENTA

Enanta Pharmaceuticals Inc
52.75
0.84 (1.62%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Enanta Pharmaceuticals Inc ENTA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.84 1.62% 52.75 16:00:18
Open Price Low Price High Price Close Price Prev Close
52.46 52.46 54.48 52.75 51.91
more quote information »

Recent News

Date Time Source Heading
2/02/20239:58IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly.
2/02/20239:30IHNWFeaturedHempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products
2/02/20237:03IHNWFeaturedAmerican Green (OTC:ERBB) Receives Equipment Lease Funding for its 40K s.f. Cypress Chill Cannabis Grow
1/31/202315:18EDGARStatement of Ownership (sc 13g)
1/31/202307:00BWEnanta Pharmaceuticals to Host Conference Call on February 7..
1/20/202316:03EDGARProxy Statement (definitive) (def 14a)
1/06/202307:00BWEnanta Pharmaceuticals to Provide Updates on its Research..
1/03/202307:00BWEnanta Pharmaceuticals to Present at the 41st Annual J.P...
11/23/202216:14EDGARAnnual Report (10-k)
11/22/202222:35TRMNSVB Securities Sticks to Its Hold Rating for Enanta..
11/22/202207:00BWEnanta Pharmaceuticals to Participate in Two Investor..
11/21/202216:02BWEnanta Pharmaceuticals Reports Financial Results for its..
11/14/202207:00BWEnanta Pharmaceuticals to Host Conference Call on November..
11/13/202222:55TRMNSVB Securities Sticks to Their Hold Rating for Enanta..
11/09/202216:35TRMNEnanta Pharmaceuticals (ENTA) Gets a Buy from JMP Securities
11/09/202207:00BWEnanta Pharmaceuticals Initiates SPRINT, a Phase 2 Clinical..
10/19/202208:00BWEnanta Pharmaceuticals Presents New Preclinical Data for..
10/17/202207:00BWEnanta Pharmaceuticals Doses First Subject in a Phase 1..
10/03/202207:00BWEnanta Pharmaceuticals Initiates a Phase 2b Clinical Study..
9/29/202207:00BWEnanta Pharmaceuticals Presents Preclinical Data for its..
9/22/202207:01BWEnanta Pharmaceuticals Announces New Preclinical Data for..
9/14/202212:25TRMNJMP Securities Sticks to Its Buy Rating for Enanta..
9/07/202208:30BWNew Preclinical Data for EDP-235, Enanta’s Oral Coronavirus..
9/01/202207:00BWEnanta Pharmaceuticals to Participate in Two Investor..
8/26/202216:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/11/202216:32EDGARInitial Statement of Beneficial Ownership (3)
8/10/202223:16TRMNSVB Securities Reaffirms Their Hold Rating on Enanta..
8/09/202208:35TRMNRBC Capital Sticks to Their Hold Rating for Enanta..
8/08/202221:45TRMNJMP Securities Keeps Their Buy Rating on Enanta..
8/08/202216:05EDGARCurrent Report Filing (8-k)
8/08/202216:03BWEnanta Pharmaceuticals Reports Financial Results for its..
8/08/202216:00BWEnanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D.,..
8/01/202208:41TRMNEnanta Pharmaceuticals (ENTA) Receives a Hold from SVB..
8/01/202207:00BWEnanta Pharmaceuticals to Host Conference Call on August 8..
7/29/202215:35TRMNJMP Securities Reiterates Their Buy Rating on Enanta..
7/29/202207:00BWEnanta Pharmaceuticals Announces Positive Data from a Phase..
7/08/202222:07TRMNRBC Capital Sticks to Its Hold Rating for Enanta..
6/23/202222:46TRMNAnalysts’ Top Healthcare Picks: Enanta Pharmaceuticals..
6/22/202206:23EDGARCurrent Report Filing (8-k)
6/21/202217:47DJNEnanta: Filed Patent Infringement Suit Against Pfizer Over..
6/21/202216:50BWEnanta Pharmaceuticals Files Patent Infringement Suit..
6/21/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202207:00BWEnanta Pharmaceuticals Announces Data Presentations at the..
6/02/202207:00BWEnanta Pharmaceuticals to Participate in Two Investor..
5/19/202223:46TRMNEvercore ISI Maintains a Sell Rating on Enanta..
5/19/202200:45TRMNJMP Securities Reaffirms Their Buy Rating on Enanta..
5/18/202216:01BWEnanta Pharmaceuticals Reports Topline Data from the RSVP..
5/11/202200:30TRMNRobert W. Baird Keeps Their Buy Rating on Enanta..
5/10/202208:44TRMNEnanta Pharmaceuticals (ENTA) Receives a Hold from SVB..
5/10/202202:15TRMNAnalysts Offer Insights on Healthcare Companies: Enanta..
5/09/202216:41EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/09/202216:13EDGARQuarterly Report (10-q)
5/09/202216:01EDGARCurrent Report Filing (8-k)